Evidence map›Paper›PMID 36978773›Full record

ArticleBioengineering (Basel, Switzerland)2023

Machine Learning Diffuse Optical Tomography Using Extreme Gradient Boosting and Genetic Programming.

Ami Hauptman, Ganesh M Balasubramaniam, Shlomi Arnon

Open access · goldFull text read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ami HauptmanDepartment of Computer Science, Sapir Academic College, Sderot 7915600, Israel.ORCID 0000-0002-3827-9735
Ganesh M BalasubramaniamDepartment of Electrical and Computer Engineering, Ben-Gurion University of the Negev, Be'er Sheva 8441405, Israel.ORCID 0000-0001-7824-5831
Shlomi ArnonDepartment of Electrical and Computer Engineering, Ben-Gurion University of the Negev, Be'er Sheva 8441405, Israel.ORCID 0000-0001-8048-3089
Ben-Gurion University of the Negev · ILSapir College · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diffuse optical tomography (DOT) is a non-invasive method for detecting breast cancer; however, it struggles to produce high-quality images due to the complexity of scattered light and the limitations of traditional image reconstruction algorithms. These algorithms can be affected by boundary conditions and have a low imaging accuracy, a shallow imaging depth, a long computation time, and a high signal-to-noise ratio. However, machine learning can potentially improve the performance of DOT by being better equipped to solve inverse problems, perform regression, classify medical images, and reconstruct biomedical images. In this study, we utilized a machine learning model called "XGBoost" to detect tumors in inhomogeneous breasts and applied a post-processing technique based on genetic programming to improve accuracy. The proposed algorithm was tested using simulated DOT measurements from complex inhomogeneous breasts and evaluated using the cosine similarity metrics and root mean square error loss. The results showed that the use of XGBoost and genetic programming in DOT could lead to more accurate and non-invasive detection of tumors in inhomogeneous breasts compared to traditional methods, with the reconstructed breasts having an average cosine similarity of more than 0.97 ± 0.07 and average root mean square error of around 0.1270 ± 0.0031 compared to the ground truth.

Indexed as

diffuse optical tomographyextreme gradient boostinggenetic programminginhomogeneous breastinverse problems

Identifiers

PMID36978773
PMCPMC10045273
OpenAlexW4328120766

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read7
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.